Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate‐to‐severe plaque psoriasis naïve to systemic treatment

A 24‐week multicentre, randomized, open‐label, parallel‐group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate‐to‐severe plaque psoriasis naive to systemic treatment

British Journal of Dermatology ◽

10.1111/bjd.18384 ◽

2019 ◽

Vol 182 (4) ◽

pp. 869-879 ◽

Cited By ~ 6

Author(s):

K. Reich ◽

M. Augustin ◽

D. Thaçi ◽

A. Pinter ◽

A. Leutz ◽

...

Keyword(s):

Fumaric Acid ◽

Plaque Psoriasis ◽

Systemic Treatment ◽

Efficacy And Safety ◽

Open Label ◽

Severe Plaque Psoriasis ◽

Fumaric Acid Esters ◽

Parallel Group Study ◽

Parallel Group ◽

Acid Esters

Guselkumab is superior to fumaric acid esters in patients with moderate‐to‐severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active‐comparator‐controlled phase IIIb trial (POLARIS)

British Journal of Dermatology ◽

10.1111/bjd.18696 ◽

2020 ◽

Vol 183 (2) ◽

pp. 265-275 ◽

Cited By ~ 5

Author(s):

D. Thaçi ◽

A. Pinter ◽

M. Sebastian ◽

C. Termeer ◽

M. Sticherling ◽

...

Keyword(s):

Fumaric Acid ◽

Plaque Psoriasis ◽

Systemic Treatment ◽

Treatment Results ◽

Active Comparator ◽

Severe Plaque Psoriasis ◽

Fumaric Acid Esters ◽

Phase Iiib ◽

Acid Esters

Efficacy and safety of fumaric acid esters in young patients aged 10 to 17 years with moderate‐to‐severe plaque psoriasis – A randomised, double‐blinded, placebo‐controlled trial

British Journal of Dermatology ◽

10.1111/bjd.19747 ◽

2020 ◽

Author(s):

H. Hamm ◽

D. Wilsmann‐Theis ◽

A. Tsianakas ◽

T. Gambichler ◽

K. Taipale ◽

...

Keyword(s):

Fumaric Acid ◽

Plaque Psoriasis ◽

Controlled Trial ◽

Young Patients ◽

Efficacy And Safety ◽

Severe Plaque Psoriasis ◽

Fumaric Acid Esters ◽

Double Blinded ◽

Acid Esters

Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate‐to‐severe plaque psoriasis (FAST)

JDDG Journal der Deutschen Dermatologischen Gesellschaft ◽

10.1111/ddg.12837 ◽

2017 ◽

Vol 15 (2) ◽

pp. 180-186 ◽

Cited By ~ 2

Author(s):

Peter Weisenseel ◽

Kristian Reich ◽

Wiebke Griemberg ◽

Katharina Merten ◽

Christine Gröschel ◽

...

Keyword(s):

Fumaric Acid ◽

Plaque Psoriasis ◽

Efficacy And Safety ◽

Severe Plaque Psoriasis ◽

Fumaric Acid Esters ◽

Acid Esters

Patient‐reported outcomes with risankizumab versus fumaric acid esters in systemic therapy‐naïve patients with moderate to severe plaque psoriasis: a phase 3 clinical trial

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.17109 ◽

2021 ◽

Author(s):

D Thaçi ◽

AM Soliman ◽

K Eyerich ◽

A Pinter ◽

M Sebastian ◽

...

Keyword(s):

Clinical Trial ◽

Fumaric Acid ◽

Plaque Psoriasis ◽

Systemic Therapy ◽

Patient Reported Outcomes ◽

Phase 3 ◽

Severe Plaque Psoriasis ◽

Fumaric Acid Esters ◽

Patient Reported ◽

Acid Esters

Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trial

British Journal of Dermatology ◽

10.1111/bjd.15707 ◽

2017 ◽

Vol 177 (4) ◽

pp. 1024-1032 ◽

Cited By ~ 27

Author(s):

M. Sticherling ◽

U. Mrowietz ◽

M. Augustin ◽

D. Thaçi ◽

N. Melzer ◽

...

Keyword(s):

Fumaric Acid ◽

Plaque Psoriasis ◽

Prime Trial ◽

Severe Plaque Psoriasis ◽

Fumaric Acid Esters ◽

Randomized Controlled ◽

Systemic Treatments ◽

Acid Esters

A phase 4, randomized, head‐to‐head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate‐to‐severe plaque psoriasis (CHANGE)

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.16932 ◽

2020 ◽

Author(s):

A. Pinter ◽

M. Hoffmann ◽

K. Reich ◽

M. Augustin ◽

K. Kaplan ◽

...

Keyword(s):

Fumaric Acid ◽

Plaque Psoriasis ◽

Subcutaneous Injections ◽

Severe Plaque Psoriasis ◽

Fumaric Acid Esters ◽

Acid Esters

Fumaric acid esters in combination with a 6-week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate-to-severe plaque psoriasis: a randomized prospective clinical stud

British Journal of Dermatology ◽

10.1111/bjd.16106 ◽

2018 ◽

Vol 178 (3) ◽

pp. 682-688 ◽

Cited By ~ 13

Author(s):

S. Tzaneva ◽

A. Geroldinger ◽

H. Trattner ◽

A. Tanew

Keyword(s):

Fumaric Acid ◽

Plaque Psoriasis ◽

Ultraviolet B ◽

Severe Plaque Psoriasis ◽

Fumaric Acid Esters ◽

Acid Esters

Fumaric acid esters in combination with a 6-week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate-to-severe plaque psoriasis: a randomized prospective clinical stud

British Journal of Dermatology ◽

10.1111/bjd.16386 ◽

2018 ◽

Vol 178 (3) ◽

pp. e233-e233

Author(s):

S. Tzaneva ◽

A. Geroldinger ◽

H. Trattner ◽

A. Tanew

Keyword(s):

Fumaric Acid ◽

Plaque Psoriasis ◽

Ultraviolet B ◽

Severe Plaque Psoriasis ◽

Fumaric Acid Esters ◽

Acid Esters

Direct Comparison of Risankizumab and Fumaric Acid Esters in Systemic–Therapy‐Naive Patients With Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial

British Journal of Dermatology ◽

10.1111/bjd.20481 ◽

2021 ◽

Author(s):

D. Thaçi ◽

K. Eyerich ◽

A. Pinter ◽

M. Sebastian ◽

K. Unnebrink ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Fumaric Acid ◽

Plaque Psoriasis ◽

Systemic Therapy ◽

Controlled Trial ◽

Severe Plaque Psoriasis ◽

Fumaric Acid Esters ◽

Randomized Controlled ◽

Acid Esters